Biotechgate

Biotechgate Global Database › Global Trial › Global Log-in ›

Database Life Science Map Statistics News & Events About us

Latest 30 News in the Life Sciences Industry

U.S. FDA approves AKEEGA® as the first precision therapy for BRCA2-mutated metastatic castration-sensitive prostate cancer with 54% reduction in disease progression vs standard of care*

Read more ››

By: PR Newswire Association LLC. - 13 Dec 2025

Accelerating Patient Recruitment and Research Excellence: TrialWire® Supports Endpoints Clinical Trials Day NYC 2025

Read more ››

By: GlobeNewswire - 13 Dec 2025

SYNEVIT® Expands West Coast Presence With Placement in Harvest Natural Foods

Read more ››

By: PR Newswire Association LLC. - 12 Dec 2025

Psylutions Leads Colorado's Regulated Psychedelic Market with Healing Center Collaborations

Read more ››

By: PR Newswire Association LLC. - 12 Dec 2025

CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››

By: GlobeNewswire - 12 Dec 2025

RadioMedix Expands Thorium-228 Supply Network Through New Agreement With Van Overeem Nuclear B.V.

Read more ››

By: GlobeNewswire - 12 Dec 2025

Hormone Replacement Therapy - FDA Removes Black Box Warning - Kass Precision Medicine

Read more ››

By: PR Newswire Association LLC. - 12 Dec 2025

Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Read more ››

By: GlobeNewswire - 12 Dec 2025

Marengo to Present Initial Results from Invikafusp Alfa and TRODELVY® Combination Study, STARt-002, at the 2025 San Antonio Breast Cancer Symposium

Read more ››

By: PR Newswire Association LLC. - 12 Dec 2025

Relay Therapeutics Announces Efficacy Subset Analysis of Zovegalisib (RLY-2608) + Fulvestrant in Breast Cancer Patients Pre-Treated with SERD or with ESR1 Mutations at SABCS 2025

Read more ››

By: GlobeNewswire - 12 Dec 2025

Emergent BioSolutions Receives U.S. FDA Approval for Drug Product Manufacturing of raxibacumab at its Winnipeg, Canada Site

Read more ››

By: GlobeNewswire - 12 Dec 2025

Oklahoma Proton Center lauds results of groundbreaking clinical study

Read more ››

By: PR Newswire Association LLC. - 12 Dec 2025

P&F secures FDA approval for TRICAV II pivotal clinical trial for severe tricuspid regurgitation

Read more ››

By: PR Newswire Association LLC. - 12 Dec 2025

GRI Bio Announces Closing of $8.0 Million Public Offering

Read more ››

By: GlobeNewswire - 12 Dec 2025

Revuforj® (revumenib) Named Best New Drug at the Scrip Awards 2025

Read more ››

By: GlobeNewswire - 12 Dec 2025

Predictive Oncology Becomes Axe Compute, Expanding Into High-Performance AI Infrastructure

Read more ››

By: GlobeNewswire - 12 Dec 2025

Insilico Medicine and TaiGen Achieves License Agreement to Develop and Commercialize AI-driven PHD Inhibitor for Anemia of Chronic Kidney Disease (CKD)

Read more ››

By: PR Newswire Association LLC. - 12 Dec 2025

Dominari Holdings Announces Change of Record Date and Payment Date for $10 Million Cash Dividend

Read more ››

By: PR Newswire Association LLC. - 12 Dec 2025

American College of Lifestyle Medicine Applauds Two New CMS Models Aligned with Lifestyle Medicine Practice and Reimbursement

Read more ››

By: PR Newswire Association LLC. - 12 Dec 2025

4DMT Announces New Employment Inducement Grants

Read more ››

By: GlobeNewswire - 12 Dec 2025

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››

By: GlobeNewswire - 12 Dec 2025

Alphyn Closes $25M Oversubscribed Series B Financing Round to Advance Dermatology Pipeline

Read more ››

By: PR Newswire Association LLC. - 12 Dec 2025

Flu Season Predicted to Be "Nasty This Winter." IQ AIR Can Help

Read more ››

By: PR Newswire Association LLC. - 12 Dec 2025

Actinium Pharmaceuticals Presents New Preclinical Data Demonstrating Potent Anti-Tumor Activity of ATNM-400 Across Multiple Breast Cancer Subtypes Including Hormone Receptor-Positive, Triple-Negative, and Tamoxifen- and HER2 Therapy-Resistant Breast

Read more ››

By: PR Newswire Association LLC. - 12 Dec 2025

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››

By: GlobeNewswire - 12 Dec 2025

Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease

Read more ››

By: GlobeNewswire - 12 Dec 2025

Global Attention: POGMENT Biomimetic Collagen "Stable Triple-Helix Breakthrough" --Unconventional and Astonishing

Read more ››

By: PR Newswire Association LLC. - 12 Dec 2025

BeyondSpring Announces ESMO Asia Presentation on Plinabulin + Docetaxel Improving Survival in Large Phase 3 DUBLIN-3 Asian Subset for EGFR WT NSCLC Compared to Docetaxel, Strengthening the Case for a Global Registration Path

Read more ››

By: GlobeNewswire - 12 Dec 2025

Chapters Health System Announces National Rebranding of Grief Support Camps for Children

Read more ››

By: PR Newswire Association LLC. - 12 Dec 2025

BioCryst Announces FDA Approval of ORLADEYO® (berotralstat) Oral Pellets, First and Only Oral Prophylactic Treatment for Patients with HAE Aged 2 to <12 Years

Read more ››

By: GlobeNewswire - 12 Dec 2025

Looking for more life science news?

Browse Biotechgate for global news, company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

January 2026
- San Francisco: 11th Annual Oncology Innovation Forum
- San Francisco: 9th Annual Neuroscience Innovation Forum
- Biotech Showcase™

Add an Event »

Latest company news

U.S. FDA approves AKEEGA® as the first precision therapy for BRCA2-mutated metastatic castration-sensitive prostate cancer with 54% reduction in disease progression vs standard of care*
13 Dec 2025 (PR Newswire Association LLC.)

Accelerating Patient Recruitment and Research Excellence: TrialWire® Supports Endpoints Clinical Trials Day NYC 2025
13 Dec 2025 (GlobeNewswire)

SYNEVIT® Expands West Coast Presence With Placement in Harvest Natural Foods
12 Dec 2025 (PR Newswire Association LLC.)

Biotechgate database

About Biotechgate
The USA Life Sciences Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com